Molecular Recognition between Aβ-Specific Single-Domain Antibody and Aβ Misfolded Aggregates
Aβ is the toxic amyloid polypeptide responsible for Alzheimer’s disease (AD). Prevention and elimination of the Aβ misfolded aggregates are the promising therapeutic strategies for the AD treatments. Gammabody, the Aβ-Specific Single-domain (VH) antibody, recogni...
Main Authors: | Mingzhen Zhang, Jie Zheng, Ruth Nussinov, Buyong Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-07-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4468/7/3/25 |
Similar Items
-
The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death
by: Sofia Söllvander, et al.
Published: (2018-03-01) -
Application of Antibody Fragments Against Aβ With Emphasis on Combined Application With Nanoparticles in Alzheimer’s Disease
by: Zhi-Ting Sun, et al.
Published: (2021-04-01) -
Editorial: Single-Domain Antibodies—Biology, Engineering and Emerging Applications
by: Kevin A. Henry, et al.
Published: (2018-01-01) -
Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications
by: Yannick Chantran, et al.
Published: (2019-07-01) -
Novel single-domain antibodies against the EGFR domain III epitope exhibit the anti-tumor effect
by: Tao Chen, et al.
Published: (2020-10-01)